147 related articles for article (PubMed ID: 30406477)
1. Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.
Rieken M; Boorjian SA; Kluth LA; Capitanio U; Briganti A; Thompson RH; Leibovich BC; Krabbe LM; Margulis V; Raman JD; Regelman M; Karakiewicz PI; Rouprêt M; Abufaraj M; Foerster B; Gönen M; Shariat SF
World J Urol; 2019 Aug; 37(8):1631-1637. PubMed ID: 30406477
[TBL] [Abstract][Full Text] [Related]
2. External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study.
Xylinas E; Kluth L; Rieken M; Rouprêt M; Al Hussein Al Awamlh B; Clozel T; Sun M; Karakiewicz PI; Gonen M; Shariat SF
Urol Oncol; 2017 Jan; 35(1):33.e21-33.e26. PubMed ID: 27816402
[TBL] [Abstract][Full Text] [Related]
3. External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based Study.
Rieken M; Kluth LA; Seitz C; Abufaraj M; Foerster B; Mathieu R; Karakiewicz PI; Bachmann A; Briganti A; Rouprê M; Gönen M; Shariat SF; Seebacher V
Clin Genitourin Cancer; 2017 Aug; ():. PubMed ID: 28916272
[TBL] [Abstract][Full Text] [Related]
4. Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
Xylinas E; Rink M; Margulis V; Faison T; Comploj E; Novara G; Raman JD; Lotan Y; Guillonneau B; Weizer A; Pycha A; Scherr DS; Seitz C; Sun M; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Gönen M; Shariat SF;
J Urol; 2013 Feb; 189(2):468-73. PubMed ID: 23253960
[TBL] [Abstract][Full Text] [Related]
5. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
Shariat SF; Rink M; Ehdaie B; Xylinas E; Babjuk M; Merseburger AS; Svatek RS; Cha EK; Tagawa ST; Fajkovic H; Novara G; Karakiewicz PI; Trinh QD; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Chun FK; Sonpavde G; Joual A; Scherr DS; Gonen M
Eur Urol; 2013 Feb; 63(2):371-8. PubMed ID: 22727174
[TBL] [Abstract][Full Text] [Related]
6. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
[TBL] [Abstract][Full Text] [Related]
7. Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis.
Capitanio U; Suardi N; Matloob R; Abdollah F; Castiglione F; Briganti A; Carenzi C; Roscigno M; Montorsi F; Bertini R
BJU Int; 2013 Mar; 111(3):412-8. PubMed ID: 22703190
[TBL] [Abstract][Full Text] [Related]
8. How to evaluate the adequacy of staging for nodal-negative epithelial ovarian cancer? Use of nodal staging score.
Xu Y; Li H; Tong X; Pang Y; Tong X; Li L; Cheng L
J Gynecol Oncol; 2019 Mar; 30(2):e21. PubMed ID: 30740953
[TBL] [Abstract][Full Text] [Related]
9. Radical Nephrectomy for Renal Cell Carcinoma: Its Contemporary Role Related to Histologic Type, Tumor Size, and Nodal Status: A Retrospective Study.
Mirza KM; Taxy JB; Antic T
Am J Clin Pathol; 2016 Jun; 145(6):837-42. PubMed ID: 27124952
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.
Gierth M; Fritsche HM; Buchner H; May M; Aziz A; Otto W; Bolenz C; Trojan L; Hermann E; Tiemann A; Müller SC; Ellinger J; Brookman-May S; Stief CG; Tilki D; Nuhn P; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Wieland WF; Riedmiller H; Denzinger S; Bastian PJ; Burger M
World J Urol; 2014 Apr; 32(2):365-71. PubMed ID: 23736527
[TBL] [Abstract][Full Text] [Related]
11. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
Shariat SF; Ehdaie B; Rink M; Cha EK; Svatek RS; Chromecki TF; Fajkovic H; Novara G; David SG; Daneshmand S; Fradet Y; Lotan Y; Sagalowsky AI; Clozel T; Bastian PJ; Kassouf W; Fritsche HM; Burger M; Izawa JI; Tilki D; Abdollah F; Chun FK; Sonpavde G; Karakiewicz PI; Scherr DS; Gonen M
Eur Urol; 2012 Feb; 61(2):237-42. PubMed ID: 22033174
[TBL] [Abstract][Full Text] [Related]
12. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
13. Pathologically examining a minimum of three lymph nodes could better determine node negativity in patients with non-metastatic chromophobe renal cell carcinoma.
Dong F; Xu L; Peng X; Xu T; Shen Y; Gao F; Wang X; Zhang X; Chen S; Zhang M; Zhong S; Ding Q
Jpn J Clin Oncol; 2018 Oct; 48(10):942-949. PubMed ID: 30137442
[TBL] [Abstract][Full Text] [Related]
14. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
[TBL] [Abstract][Full Text] [Related]
15. Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model.
Gershman B; Takahashi N; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
BJU Int; 2016 Nov; 118(5):742-749. PubMed ID: 26800148
[TBL] [Abstract][Full Text] [Related]
16. Use of Nodal Staging Score in Evaluating the Accuracy of Pathologic Nodal Status in Node-Negative Ampullary Carcinoma.
Huang XT; Huang CS; Li JH; Xu QC; Yin XY
J Gastrointest Surg; 2021 Apr; 25(4):1001-1009. PubMed ID: 32253644
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinoma.
Radadia KD; Rivera-Núñez Z; Kim S; Farber NJ; Sterling J; Falkiewicz M; Modi PK; Goyal S; Parikh R; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Urol Oncol; 2019 Sep; 37(9):577.e17-577.e25. PubMed ID: 31280982
[TBL] [Abstract][Full Text] [Related]
18. Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
Sun M; Bianchi M; Hansen J; Abdollah F; Trinh QD; Lughezzani G; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
Int J Urol; 2013 Apr; 20(4):372-80. PubMed ID: 23039208
[TBL] [Abstract][Full Text] [Related]
19. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
[TBL] [Abstract][Full Text] [Related]
20. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer.
Gönen M; Schrag D; Weiser MR
J Clin Oncol; 2009 Dec; 27(36):6166-71. PubMed ID: 19901106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
